CDC advisory committee recommends COVID vaccine for 12- to 15-year-olds

A masked child watches a healthcare worker perform an injection.

Enlarge / With new knowledge, we’re in a position to broaden vaccinations to ever-younger populations. (credit score: Roberto Jimenez Mejias / Getty Photographs)

On Wednesday, the CDC’s Advisory Committee on Immunization Practices really helpful that the CDC approve the usage of the Pfizer/BioNTech COVID-19 vaccine for the 12- to 15-year age group. The choice comes two days after the FDA granted an emergency use authorization for a similar age group and can assist the US additional restrict the pool of people that can unfold infections or foster the evolution of recent viral variants. Formal CDC approval might come rapidly, given current historical past.

Given the FDA’s earlier determination, the transfer might sound anticlimactic. However having the FDA and CDC formally on the identical web page is reassuring, and a number of other state-run vaccination applications are awaiting the CDC’s OK earlier than increasing into that age group. Personal suppliers and insurance coverage firms have been additionally diverse of their response to the FDA’s determination and have been ready for the CDC.

The info that supported the approval was fairly decisive, as a small Part III medical trial of two,260 adolescents noticed 16 instances of COVID-19, with each single one occurring within the placebo group. Negative effects have been much like these skilled by older individuals, with a short interval of flu-like signs. The committee was tasked with contemplating whether or not the advantages outweighed the dangers; given the minor unwanted side effects and the more and more apparent advantages of vaccination, it is not a shock that the vote in favor of approval by the committee was 14 in favor, none opposing, and a single recusal. The CDC director, Rochelle Walensky, is overwhelmingly more likely to observe the committee’s advice, almost certainly earlier than the day is over. (We’ll replace this story if and when this happens.)

Learn 2 remaining paragraphs | Feedback

Tagged : / / / / / / /

FDA authorizes Pfizer’s COVID-19 vaccine for 12- to 15-year-olds

An illustration picture shows vials with COVID-19 Vaccine stickers attached, with the logo of US pharmaceutical company Pfizer, on November 17, 2020.

Enlarge / An illustration image reveals vials with COVID-19 Vaccine stickers connected, with the emblem of US pharmaceutical firm Pfizer, on November 17, 2020. (credit score: Getty | JUSTIN TALLIS)

The US Meals and Drug Administration has licensed the usage of the Pfizer-BioNTech COVID-19 vaccine in adolescents between the ages of 12 to 15, the company introduced Monday night.

Within the announcement, performing FDA Commissioner Janet Woodcock referred to as the authorization “a big step within the struggle in opposition to the COVID-19 pandemic” that can convey the nation “nearer to returning to a way of normalcy and to ending the pandemic.”

Peter Marks, director of the FDA’s Middle for Biologics Analysis and Analysis, echoed that sentiment. He referred to as the flexibility to vaccinate kids and youths “a essential step” within the struggle in opposition to COVID-19.

Learn 7 remaining paragraphs | Feedback

Tagged : / / / / /

Biden shifts technique as nationwide vaccination charge continues to sluggish

An older man in a suit gestures while addressing an unseen crowd.

Enlarge / US President Joe Biden speaks within the State Eating Room of the White Home in Washington, DC, on Tuesday, Could 4, 2021. (credit score: Getty | Bloomberg)

By July 4—two months from as we speak—the Biden administration desires to have 70 % of American adults vaccinated with no less than one dose of a COVID-19 vaccine and 160 million adults absolutely vaccinated.

At present, over 147.5 million folks have obtained no less than one shot, which is 44 % of the general inhabitants and consists of 56 % of adults (folks ages 18 and up). Over 105 million persons are absolutely vaccinated, which is sort of 32 % of the general inhabitants and consists of practically 41 % of adults.

The administration’s new objective would imply that near 100 million pictures must exit within the subsequent 60 days or so, President Joe Biden stated in an handle Tuesday afternoon.

Learn 7 remaining paragraphs | Feedback

Tagged : / / / / / / / / /

FDA reportedly plans to authorize Pfizer’s COVID vaccine for teenagers 12-15 in days

Vials with COVID-19 Vaccine labels showing logos of pharmaceutical company Pfizer and German biotechnology company BioNTech.

Enlarge / Vials with COVID-19 Vaccine labels exhibiting logos of pharmaceutical firm Pfizer and German biotechnology firm BioNTech. (credit score: Getty | Photonews)

The Meals and Drug Administration is planning to authorize the usage of Pfizer-BioNTech’s COVID-19 vaccine in adolescents 12 to 15 years outdated later this week or early subsequent week, in keeping with a report by The New York Occasions.

The Occasions cited unnamed federal officers who didn’t have authorization to talk publicly in regards to the FDA’s plans. If the FDA does authorize use of the vaccine within the teen group within the week, the Facilities for Illness Management and Prevention’s vaccine advisory panel will probably meet a day later to evaluate the scientific trial knowledge and make a advice on use, the Occasions reported.

On March 31, Pfizer introduced that the vaccine fully protected adolescents ages 12 to 15 towards COVID-19 in a small Section III scientific trial. The vaccine was additionally well-tolerated within the age group, producing primarily commonplace unwanted side effects.

Learn 5 remaining paragraphs | Feedback

Tagged : / / / / / /

Contractor that ruined 15M doses of J&J vaccine is holding up vaccine to India

Funeral pyres of people who died of COVID-19 being prepared simultaneously at Gazipur crematorium on April 26, 2021 in New Delhi, India.

Enlarge / Funeral pyres of people that died of COVID-19 being ready concurrently at Gazipur crematorium on April 26, 2021 in New Delhi, India. (credit score: Getty | Raj Ok Raj)

India’s skyrocketing surge of COVID-19 circumstances has launched the nation into probably the most harrowing disaster but within the pandemic.

Whereas worldwide help pours into the nation, many have referred to as for the US to donate tens of millions of doses from its stockpile of AstraZeneca’s COVID-19 vaccine to India, which has vaccinated lower than 2 % of its inhabitants and is operating out of doses.

AstraZeneca’s vaccine is broadly used all over the world, together with in India, however it isn’t but licensed to be used within the US. Even when it does earn authorization right here, Biden administration officers say it’s unlikely that the US will want the vaccine, given the wholesome amount of provides of the three COVID-19 vaccines already licensed within the nation made by Moderna, Pfizer-BioNTech, and Johnson & Johnson.

Learn 17 remaining paragraphs | Feedback

Tagged : / / / / / / / /

Pause of J&J vaccine was the suitable name, say 88% of polled People

A large streetside sign for a Johnson and Johnson vaccine.

Enlarge / Basic exterior view of the top workplace of Janssen pharmaceutical firm on April 15, 2021 in Leiden, Netherlands. (credit score: Getty | BSR Company)

About 88 p.c of People help the pause of Johnson & Johnson’s COVID-19 vaccine, and the pause did not improve vaccine hesitancy, based on contemporary information from the Axios-Ipsos Coronavirus ballot.

The discovering is more likely to hearten public well being consultants, who’ve confronted criticism and concern that the pause may erode confidence in vaccine security and fortify already high-levels of vaccine hesitancy within the nation.

The Facilities for Illness Management and Prevention, together with the Meals and Drug Administration, beneficial a pause in the usage of the Johnson & Johnson vaccine on April 13 after linking the one-dose vaccine to 6 instances of a uncommon blood-clotting situation, one among which was deadly. The six instances occurred amongst greater than 6.eight million individuals given the vaccine, suggesting that if the blood clots are, in actual fact, a facet impact of the vaccine, they’re a particularly uncommon facet impact.

Learn 11 remaining paragraphs | Feedback

Tagged : / / / / / / / /

Extra J&J troubles: Vaccine manufacturing halted and extra doable clot circumstances

The Emergent BioSolutions plant, a manufacturing partner for Johnson & Johnson's Covid-19 vaccine, in Baltimore, Maryland, on April 9, 2021.

Enlarge / The Emergent BioSolutions plant, a producing associate for Johnson & Johnson’s Covid-19 vaccine, in Baltimore, Maryland, on April 9, 2021. (credit score: Getty | Saul Loeb)

The US Meals and Drug Administration final week requested Emergent BioSolutions to cease making Johnson & Johnson’s COVID-19 vaccine at its troubled facility in Baltimore, in response to a regulatory submitting Emergent launched Monday.

The FDA had begun an inspection of the contract producer’s facility on April 12 however requested on April 16 that manufacturing be halted “pending completion of the inspection and remediation of any ensuing findings,” the submitting reads. Any vaccine supplies already made on the plant shall be held in quarantine.

The manufacturing halt follows information final month {that a} mishap on the plant led to the spoil of 15 million doses of Johnson & Johnson’s one-shot COVID-19 vaccine. The ruined doses had reportedly been contaminated with substances from AstraZeneca’s COVID-19 vaccine, which was additionally being manufactured on the plant on the time.

Learn 10 remaining paragraphs | Feedback

Tagged : / / / / / / / / /

Manufacturing facility mix-up spoils 15 million doses of J&J COVID vaccine

A sign at the Johnson & Johnson campus on August 26, 2019 in Irvine, California.

Enlarge / An indication on the Johnson & Johnson campus on August 26, 2019 in Irvine, California. (credit score: Getty | Mario Tama)

About 15 million doses of Johnson & Johnson’s one-shot COVID-19 vaccine had been ruined, and future vaccine shipments might be delayed. This all follows a mix-up at a producing facility in Baltimore, in accordance with a number of media experiences.

Johnson & Johnson had partnered with Emergent BioSolutions to fabricate the energetic ingredient of its vaccine. However in accordance with two US officers who spoke with Politico, staff on the West Baltimore facility combined up the components in Johnson &Johnson’s vaccine with these for a special coronavirus vaccine. Emergent BioSolutions can be a producing accomplice of AstraZeneca, in accordance with the New York Instances, which first reported the issue.

The mishap with Johnson & Johnson’s vaccine started earlier than the Meals and Drug Administration had licensed the ability to supply the vaccine. Now, that authorization has been delayed and shipments are stalled.

Learn four remaining paragraphs | Feedback

Tagged : / / / / / / / / /

After dramatic rebuke, AstraZeneca lowers vaccine efficacy estimate—a bit of

A vial of the AstraZeneca/Oxford vaccine is pictured at a coronavirus vaccination center at the Wanda Metropolitano stadium in Madrid on March 24, 2021.

Enlarge / A vial of the AstraZeneca/Oxford vaccine is pictured at a coronavirus vaccination middle on the Wanda Metropolitano stadium in Madrid on March 24, 2021. (credit score: Getty | Gabriel Bouys)

Brushing apart a dramatic rebuke from authorities researchers and unbiased specialists, AstraZeneca on Wednesday evening introduced {that a} new evaluation discovered its COVID-19 vaccine to be 76 p.c efficient at stopping symptomatic COVID-19—down from the 79 p.c efficacy estimate it introduced in a press launch Monday.

The brand new estimate remains to be excessive, in response to an unbiased board of specialists tasked with overseeing the vaccine’s trial and information evaluation. The trial’s Information and Security Monitoring Board (DSMB) despatched a extremely uncommon letter to AstraZeneca quickly after the Monday press launch, noting that trial information it had seen throughout February and March conferences urged that the vaccine’s efficacy was really between 69 p.c and 74 p.c.

“The DSMB is worried that AstraZeneca selected to make use of information that was already outdated and doubtlessly deceptive of their press launch,” the letter acknowledged. “The purpose that’s clear to the board is that the [vaccine efficacy number]… they selected to launch was essentially the most favorable for the examine versus the newest and most full. Choices like this are what erode public belief within the scientific course of.”

Learn eight remaining paragraphs | Feedback

Tagged : / / / / / /

FDA panel votes unanimously in favor of authorizing J&J vaccine

A sign at the Johnson & Johnson campus on August 26, 2019 in Irvine, California.

Enlarge / An indication on the Johnson & Johnson campus on August 26, 2019 in Irvine, California. (credit score: Getty | Mario Tama)

After a day-long assembly Friday, an advisory panel for the US Meals and Drug Administration voted 22 to zero to advocate issuing an Emergency Use Authorization for Johnson & Johnson’s single-shot, refrigerator-stable COVID-19 vaccine.

If the FDA accepts the panel’s advice and grants the EUA—which it probably will—the nation could have a 3rd COVID-19 vaccine approved to be used. Earlier this week, FDA scientists launched their evaluation of the vaccine, endorsing authorization. In the present day’s panel, the FDA’s Vaccines and Associated Organic Merchandise Advisory Committee (VRBPAC) went by means of the info additional.

“It’s a comparatively straightforward name,” Eric Rubin, a Harvard researcher and voting member of the VRBPAC mentioned after the vote. “[The vaccine] clearly will get approach over the bar and it’s good to have a single-dose vaccine… the demand is so giant [for vaccines], it clearly has a spot.”

Learn 9 remaining paragraphs | Feedback

Tagged : / / / / / / / /